Collaboration to jointly develop Indonesia’s cosmetics and personal care market under a "Made in Indonesia, Powered by Japanese Formulation Expertise" concept.

Key Facts

  • Route to market: PARVA is affiliated with DELTASPA Group, a spa chain operating approximately 25 locations across Indonesia, providing an established distribution network from day one.
  • Proven sales playbook: Products from PARVA’s facility will be sold using the B2B and offline & online B2C sales and sales management methods Instinct Bio has built over many years in Japan, supporting rapid establishment of a sales base in Indonesia.
  • Local manufacturing: The parties intend to use PARVA’s existing BPOM-recognized facility, manufacturing to GMP standards and Japanese GVP/GQP quality frameworks.
  • Halal readiness: Products will be manufactured to comply with Indonesia’s regulatory requirements, including halal certification for cosmetics circulating in Indonesia, allowing the collaboration to respond proactively to market demand.
  • Intellectual property: Instinct Bio retains ownership of proprietary ingredients and formulations, granting limited licenses.
  • Revenue streams: In addition to a 50% profit share, Instinct Bio expects revenue from proprietary ingredient supply, formulation royalties, and brand licensing fees for its GENRÊVER and HAKUA brands.
  • Indonesia platform: The collaboration is the third component of the Company’s organic growth strategy, following the integrated GENRÊVER CLINIC announcement (July 29, 2026) and the collaboration with Invitrx Therapeutics, Inc. (July 30, 2026).
  • Market Context: Indonesia’s beauty and personal care market is estimated at approximately US$10.5 billion in 2026, growing approximately 5.5% annually (source: Statista Market Insights, Beauty & Personal Care — Indonesia).